1. Home
  2. INTJ vs JAGX Comparison

INTJ vs JAGX Comparison

Compare INTJ & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTJ
  • JAGX
  • Stock Information
  • Founded
  • INTJ 2016
  • JAGX 2013
  • Country
  • INTJ Hong Kong
  • JAGX United States
  • Employees
  • INTJ N/A
  • JAGX N/A
  • Industry
  • INTJ
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTJ
  • JAGX Health Care
  • Exchange
  • INTJ NYSE
  • JAGX Nasdaq
  • Market Cap
  • INTJ 12.7M
  • JAGX 12.9M
  • IPO Year
  • INTJ 2024
  • JAGX N/A
  • Fundamental
  • Price
  • INTJ $1.14
  • JAGX $1.15
  • Analyst Decision
  • INTJ
  • JAGX
  • Analyst Count
  • INTJ 0
  • JAGX 0
  • Target Price
  • INTJ N/A
  • JAGX N/A
  • AVG Volume (30 Days)
  • INTJ 206.8K
  • JAGX 676.9K
  • Earning Date
  • INTJ 01-14-2025
  • JAGX 11-13-2024
  • Dividend Yield
  • INTJ N/A
  • JAGX N/A
  • EPS Growth
  • INTJ 30.19
  • JAGX N/A
  • EPS
  • INTJ 0.07
  • JAGX N/A
  • Revenue
  • INTJ $2,341,977.00
  • JAGX $10,480,000.00
  • Revenue This Year
  • INTJ N/A
  • JAGX $18.18
  • Revenue Next Year
  • INTJ N/A
  • JAGX $40.06
  • P/E Ratio
  • INTJ $16.39
  • JAGX N/A
  • Revenue Growth
  • INTJ 25.78
  • JAGX N/A
  • 52 Week Low
  • INTJ $0.82
  • JAGX $0.84
  • 52 Week High
  • INTJ $7.87
  • JAGX $21.60
  • Technical
  • Relative Strength Index (RSI)
  • INTJ N/A
  • JAGX 60.03
  • Support Level
  • INTJ N/A
  • JAGX $0.97
  • Resistance Level
  • INTJ N/A
  • JAGX $1.10
  • Average True Range (ATR)
  • INTJ 0.00
  • JAGX 0.08
  • MACD
  • INTJ 0.00
  • JAGX 0.02
  • Stochastic Oscillator
  • INTJ 0.00
  • JAGX 92.17

About INTJ INTELLIGENT GROUP LTD

Intelligent Group Ltd is a professional services provider in Hong Kong that principally engages in the provision of Financial PR services. The company provides a substantial number of holistic and comprehensive Financial PR services to its clients through IJL, its key operating entity in Hong Kong. It advises its clients on their communications and reputation management efforts. Its Financial PR services include creating multi-stakeholder communications programs, arranging press conferences and interviews, participating in the preparation of news releases and shareholders' meetings, monitoring news publications, identifying shareholders, targeting potential investors, organizing corporate events, and implementing crisis management policies and procedures.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: